Camlin Fine Sciences Ltd (CAMLINFINE) Q4FY26 Concall Summary - Mar-2026 Qtr
Performance Overview
- The company's performance in the quarter was significantly impacted by global conflicts, leading to a 20% reduction in sales due to shipment delays, lack of ships, and increased voyage times, which also strained working capital cycles.
- Despite challenges, the Blends business continued its steady growth trajectory, clocking a 17% increase, narrowly missing the 20% target primarily due to liquidity issues at the newly acquired Win-5 entity.
- The Vanillin business is showing positive signs with improved price realizations, which increased from sub-$11 to over $12.5 per kg in Q4, driven by the withdrawal of high tariffs in the US market.
- The company successfully liquidated its CFS Europe subsidiary, resulting in a one-time gain of approximately INR 100 crores and eliminating an annual cash burn of INR 50-60 crores from the discontinued operation.
- Management has strategically decided to temporarily halt the production of Diphenyl (Hydroquinone and Catechol) due to a sharp increase in the price of its key raw material, phenol, from INR 85 to over INR 150 per kg, opting to import Hydroquinone to maintain downstream production.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.